Let’s Talk About It: Triple-Negative Breast Cancer - Cutting-Edge Research on TNBC

Researchers from the University of Arizona have developed a drug compound that appears to stop cancer cell growth in what's known as triple-negative breast cancer. The drug, which has not yet been tested in humans, has been shown to eliminate tumors in mice, with little to no effect on normal healthy cells, making it potentially nontoxic for patients. The therapy is based on a newly discovered way that a gene known as epidermal growth factor receptor, or EGFR, leads to cancer. EGFR is a long-investigated oncogene—a gene that in certain circumstances can transform a cell into a tumor cell. Join our facilitator Nancy Touhill as she speaks with a researcher to breakdown this information for the TNBC community.

For more information, visit our website at sharecancersupport.org or call our Helpline at 844.ASK.SHARE (844.275.7427).